CXCL8 and neoplasm: Our experimental data suggest that DARC isoforms in the tumor microenvironment could reduce the levels of pro-malignant chemokines (such as CCL2, CCL5, and CXCL8) in different degrees, have differential effects on tumor growth and vascularization, and contribute to differential potential of metastasis.